Fundraising Fox

Seroba Lifesciences

also invests · investor profile

3 known investors

This page is a news post from Azafaros, a biopharmaceutical company developing disease-modifying therapeutics for lysosomal storage disorders with a focus on neurological symptoms. The domain belongs to Seroba Life Sciences, but the visible content only covers an Azafaros clinical trial announcement rather than describing the site owner itself.

Biotech

Investors · 3

CDP Venture CapitalRome
OrbiMedreportedNew York · $1M – $75M

Also in the syndicate · 1

Seroba

Funding

SEC filings, press & company announcements
  • Undisclosed amountSeries ASep 2024

    Seroba

    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

"Biotech and Healthcare: The Venture Capital and Private Equity Perspective" by Invest Europe – Seroba Lifesciencesserobavc.com · Nov 2025Seroba Announces Its investment in Ryme Medical as Part of Series A Financing – Seroba Lifesciencesserobavc.com · Sep 2024Seroba confirme ses ambitions françaises Biotech Finances – Seroba Lifesciencesserobavc.com · Dec 2023Western Development Commission invests €2m in Atlantic Therapeutics – Seroba Lifesciencesserobavc.com · Feb 2021Fusion Raises $105m in Series B Financing – Seroba Lifesciencesserobavc.com · Apr 2019

Frequently asked questions

What does Seroba Lifesciences do?
This page is a news post from Azafaros, a biopharmaceutical company developing disease-modifying therapeutics for lysosomal storage disorders with a focus on neurological symptoms. The domain belongs to Seroba Life Sciences, but the visible content only covers an Azafaros clinical trial announcement rather than describing the site owner itself.
Who are Seroba Lifesciences's investors?
Seroba Lifesciences's investors include CDP Venture Capital, OrbiMed.